Iradimed (IRMD) Non-Current Deferred Tax Liability (2013)
Iradimed (IRMD) reported Non-Current Deferred Tax Liability of $54087.0 for Q4 2013.
Iradimed (IRMD) Non-Current Deferred Tax Liability (2013) Analysis & Trends
Iradimed (IRMD) has 1 years of Non-Current Deferred Tax Liability data on file, last reported at $54087.0 in Q4 2013.
- Non-Current Deferred Tax Liability for Q4 2013 came in at $54087.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2013 was $54087.0 (changed N/A YoY), and the FY2013 annual result was $54087.0, changed N/A from the prior year.
- Non-Current Deferred Tax Liability was little changed at $54087.0 in Q4 2013 per IRMD's latest filing.
- Over five years, Non-Current Deferred Tax Liability peaked at $54087.0 in Q4 2013 and troughed at $54087.0 in Q4 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn |
| 10 | Iradimed | 1.21 Bn | 1.16 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 54,087.00 |
| Dec 31, 2013 | 54,087.00 |